Unknown PHASE2 INTERVENTIONAL 2-arm NCT03448510

Irreversible Electroporation Versus Standard Medication for Benign Prostatic Obstruction

The Safety and Efficacy of Irreversible Electroporation Versus Standard Medication for the Treatment of Benign Prostatic Obstruction: a Randomized Controlled Trial

Sponsor: Changhai Hospital

Conditions Lower Urinary Tract Symptoms

Interventions Irreversible electroporation Standard Medication

Updated 5 times since 2018 Last updated: Feb 22, 2018 Started: Apr 1, 2018 Primary completion: Jan 31, 2019 Completion: May 30, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Lower Urinary Tract Symptoms, this trial is ongoing. The trial is conducted by Changhai Hospital and has accumulated 5 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Mar 2020 — Jan 2021 [monthly]

Unknown Status PHASE2

Status: Not Yet Recruiting → Unknown Status
Mar 2018 — Mar 2020 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Changhai Hospital

Data source: Changhai Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shanghai, China